5 Results for "

ZAK

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ZAK" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
Cat. No.: HY-128326
CAS No.: 2362525-64-0
Target:  

MAP3K

Research Areas:  

Cardiovascular Disease

ZAK-IN-1 is an orally active and selective selective leucine-zipper and sterile‑α motif kinase (ZAK) inhibitor with IC50 of 4 nM and KD of 8 nM. ZAK-IN-1 exhibits excellent selectivity against a panel of 403 wild-type kinases. ZAK-IN-1 blocks p38/GATA-4 and JNK/c-Jun signaling and shows promising anti antihypertrophic cardiomyopathy (HCM) efficacy. ZAK-IN-1 can be used for the study of HCM .
loading...
    loading...
Cat. No.: HY-160196
CAS No.: 2803470-63-3
Synonyms: GCN2 modulator-1
Research Areas:  

Cancer

HC-7366 (GCN2 modulator-1) is an orally effective GCN2 activator. HC-7366 can effectively compete and occupy the ATP binding pocket of GCN2, with its IC50 being 72 nM. This binding triggers the conformational activation of GCN2, leading to the upregulation of downstream signals (such as ATF4, ASNS) in the integrated stress response (ISR) pathway, ultimately exerting anti-tumor effects. HC-7366 also has inhibitory activity against ZAK, with its IC50 being 47 nM. HC-7366 can be used for research on fibrosarcoma and acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-136848
CAS No.: 2088179-99-9
Purity:  96.09%
SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines .
loading...
    loading...
Cat. No.: HY-182103
CAS No.: 3033697-19-4
Target:  

MAP3K Caspase p38 MAPK

Research Areas:  

Cardiovascular Disease

ZAK-IN-2 (Compound 8) is a selective, covalent ZAK inhibitor with an IC50 of 11.5 nM. ZAK-IN-2 forms a covalent bond with Cys22 in the P-loop of ZAK to inhibit its kinase activity. ZAK-IN-2 inhibits the phosphorylation of the downstream target p38. ZAK-IN-2 blocks Doxorubicin (HY-15142A)-induced cleavage of Caspase 3. ZAK-IN-2 is applicable to research related to myocardial hypertrophy .
loading...
    loading...
Cat. No.: HY-RS08055
Research Areas:  

Others

MAP3K20 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP3K20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...